Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study

References

• Fox CS, Golden SH, Anderson C, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777–1803. doi:10.2337/dci15-001226246459
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani M, DeFronzo RA, Del Prato S, Chilton R, Singh R, Ryder REJ. Cardiovascular disease and type 2 diabetes: has the dawn of a new era arrived? Diabetes Care. 2017;40(7):813–820. doi:10.2337/dc16-273628637886
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. Guidance and guidelines. NICE. Available from: https://www.nice.org.uk/guidance/ng28. Accessed 713, 2017.
   Google Scholar
• Standards of Medical Care in Diabetes. American Diabetes Association. Available from: https://professional.diabetes.org/content-page/standards-medical-care-diabetes. Accessed 317, 2018.
   Google Scholar
• Chamberlain JJ, Rhinehart AS, Shaefer CF, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2016;164(8):542–552. doi:10.7326/M15-301626928912
   PubMed Web of Science ®Google Scholar
• Svensson E, Baggesen LM, Johnsen SP, et al. Early glycemic control and magnitude of HbA1c reduction predict cardiovascular events and mortality: population-based cohort study of 24,752 metformin initiators. Diabetes Care. 2017;40(6):800–807. doi:10.2337/dc16-227128404659
   PubMed Web of Science ®Google Scholar
• King P, Peacock I, Donnelly R. The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643–648. doi:10.1046/j.1365-2125.1999.00092.x10594464
   PubMed Web of Science ®Google Scholar
• Gaede P, Lund-Andersen H, Parving -H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–591. doi:10.1056/NEJMoa070624518256393
   PubMed Web of Science ®Google Scholar
• O’Keeffe AG, Geneletti S, Baio G, Sharples LD, Nazareth I, Petersen I. Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data. BMJ. 2014;349:g5293. doi:10.1136/bmj.g529325199521
   PubMed Web of Science ®Google Scholar
• Bor J, Moscoe E, Mutevedzi P, Newell M-L, Bärnighausen T. Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology. 2014;25(5):729–737. doi:10.1097/EDE.000000000000013825061922
   PubMed Web of Science ®Google Scholar
• Moscoe E, Bor J, Bärnighausen T. Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice. J Clin Epidemiol. 2015;68(2):132–143. doi:10.1016/j.jclinepi.2014.06.021
   Web of Science ®Google Scholar
• Grann ER, Nielsen F, Thomsen R. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol. 2011;3:133–138. doi:10.2147/CLEP.S1790121487452
   PubMedGoogle Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Ehrenstein V. Existing data sources for clinical epidemiology: aarhus university prescription database. Clin Epidemiol. 2010;2:273–279. doi:10.2147/CLEP.S1345821152254
   PubMedGoogle Scholar
• Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
   PubMed Web of Science ®Google Scholar
• Thistlethwaite DL, Campbell DT. Regression-discontinuity analysis: an alternative to the ex post facto experiment. J Educ Psychol. 1960;51(6):309–317. doi:10.1037/h0044319
   Web of Science ®Google Scholar
• Lee DS. Randomized experiments from non-random selection in U.S. House elections. J Econom. 2008;142(2):675–697. doi:10.1016/j.jeconom.2007.05.004
   Web of Science ®Google Scholar
• Imbens G, Lemieux T. Regression discontinuity designs: a guide to practice. J Econom. 2008;142(2):615–635. doi:10.1016/j.jeconom.2007.05.001
   Web of Science ®Google Scholar
• Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006;49(8):1711–1721. doi:10.1007/s00125-006-0316-216802130
   PubMed Web of Science ®Google Scholar
• Hulman A, Simmons RK, Brunner EJ, et al. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. Diabetologia. 2017;60(7):1252–1260. doi:10.1007/s00125-017-4275-628409212
   PubMed Web of Science ®Google Scholar
• Thrasher J. Pharmacologic management of type 2 diabetes mellitus: available therapies. Am J Med. 2017;130(6S):S4–S17. doi:10.1016/j.amjmed.2017.04.00428526182
   PubMed Web of Science ®Google Scholar
• Vistisen D, Witte DR, Brunner EJ, et al. Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II Study. Diabetes Care. 2018;41(4):899–906. doi:10.2337/dc17-253029453200
   PubMed Web of Science ®Google Scholar
• Arnetz L, Ekberg NR, Alvarsson M. Sex differences in type 2 diabetes: focus on disease course and outcomes. Diabetes Metab Syndr Obes Targets Ther. 2014;7:409–420. doi:10.2147/DMSO.S51301
   PubMedGoogle Scholar
• Roche MM, Wang PP. Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care. 2013;36(9):2582–2590. doi:10.2337/dc12-127223564923
   PubMed Web of Science ®Google Scholar